Drug shortage
Glycopyrrolate Injection · Fresenius Kabi USA, LLC
FDA drug shortage · To Be Discontinued · updated Jul 30, 2026
Key facts
| Generic name | Glycopyrrolate Injection |
|---|---|
| Company | Fresenius Kabi USA, LLC |
| Presentation | Glycopyrrolate, Injection, 0.4 mg per 2 mL (NDC 63323-578-02) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Anesthesia |
| Package NDCs | 63323-578-02 |
| First posted | Jul 30, 2026 |
| Last updated | Jul 30, 2026 |
| Discontinued | Jul 30, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: